HSBC Holdings’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-22,460
Closed -$86K 3185
2021
Q1
$86K Sell
22,460
-13,545
-38% -$55.9K ﹤0.01% 2645
2020
Q4
$152K Buy
36,005
+2,801
+8% +$10.8K ﹤0.01% 2885
2020
Q3
$128K Sell
33,204
-16,788
-34% -$71.4K ﹤0.01% 2587
2020
Q2
$218K Buy
49,992
+29,050
+139% +$131K ﹤0.01% 2313
2020
Q1
$79K Sell
20,942
-3,643
-15% -$17.9K ﹤0.01% 2504
2019
Q4
$157K Buy
+24,585
New +$145K ﹤0.01% 2867

Other funds holding BDSI

HSBC Holdings's BDSI Position: Q2 2021 in Review

HSBC Holdings sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2021, closing a stake of 22,460 shares — an estimated $86K sold.

HSBC Holdings first reported a position in BDSI in Q4 2019 and held it in 6 quarters. The position peaked at $218K in Q2 2020. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2021.

  • HSBC Holdings reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2021 after selling out during the quarter.
  • HSBC Holdings sold 22,460 BioDelivery Sciences International, Inc. shares in Q2 2021, an estimated $86K.
  • HSBC Holdings first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 6 quarters.
  • HSBC Holdings's BioDelivery Sciences International, Inc. position peaked at $218K in Q2 2020.
  • 143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2021.

Based on HSBC Holdings's 13F filing for Q2 2021, filed 13 Aug 2021.